Open | 0.68 |
Previous Close | 0.6599 |
Day Range | 0.64 - 0.70 |
52-Week Range | 0.56 - 2.11 |
All-Time High | 1,408.00 |
Avg. Volume (50-day) | 1,196,932.8 |
EPS (TTM) | -0.9823 |
Next Earnings Date | 2025-08-07 (AMC) |
Last Earnings Date | 2025-05-15 |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | Yes |
P/E Ratio | -0.6700 |
PEG Ratio | - |
Price to Book | -11.25 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | - |
Revenue per Share (TTM) | - |
Shares Outstanding | 95.817 M |
Share Float (%) | 92.92 M |
% Held by Institutions | 40.58 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 0.9 (-22.22%) |
+/- SMA(50) | 1.01 (-30.69%) |
+/- SMA(200) | 1.19 (-41.18%) |
5-Day Perf. | -23.71% |
1-Month Perf. | -39.13% |
3-Month Perf. | -41.18% |
6-Month Perf. | -50% |
YTD Perf. | -30% |
1-Year Perf. | -43.55% |
RSI(14) | 31.04 |
ATR(14) | 0.09 |
ADX(14) | 25.79 |
Beta (5Y) | 0.77 |
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. The firm’s products include IMU-838, IMU-935, and IMU-856. The company was founded in May 2003 and is headquartered in New York, NY.
IMUX has triggered the following predefined scans:
P&F Double Bottom Breakdown |
P&F Descending Triple Bottom Breakdown |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.